CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients

Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang

Clin Mol Hepatol. 2012;18(1):41-47. Published online 2012 March 22 DOI: https://doi.org/10.3350/kjhep.2012.18.1.41

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients

Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang

The Korean Journal of Hepatology. 2012;18(1):41

Link1 Link2 Link3

W1007 Rapid Virologic Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virologic Response and Relapse

F. Fred Poordad, Chrispin Kambili

Gastroenterology. 2008;134(4):A-830

Link1 Link2

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh, V. K. Rustgi

Journal of Viral Hepatitis. 2007;070701233506001-???

Link1 Link2

Review: Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients

Fred Poordad, Carmen Landaverde

Therapeutic Advances in Gastroenterology. 2009;2(2):91-97

Link1 Link2

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

Maria Buti, Francisco Sanchez-Avila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, Maria Martell, Rafael Esteban

Hepatology. 2002;35(4):930-936

Link1 Link2 Link3

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response

A. Craxi, S. Koutsounas, P. Ogurtsov, L. Chemello, M. Maticic, J. Torras, M. Diago, M. T. Tartaglione, T. Witthoeft, X. Yu, R. Faruqi, E. Chaudhri, L. D. Pedicone, E. Zuckerman

Journal of Viral Hepatitis. 2011;19(2):e120-e125

Link1 Link2

503 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with chronic hepatitis C (CHC) and persistently normal alanine aminotransferase (ALT) levels

P.J. Pockros, M. Diago, E. Gane, K.R. Reddy, D. Prati, M.L. Shiffman, P. Farci, C. O'Brien, P. Lardelli, F. Lamour, S. Zeuzem

Journal of Hepatology. 2004;40:148

Link1 Link2

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

M. Rodriguez-Torres, M. S. Sulkowski, R. T. Chung, F. M. Hamzeh, D. M. Jensen

Journal of Viral Hepatitis. 2010;17(2):139-147

Link1 Link2

The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase*

J. Hornberger, P. Farci, D. Prati, S. Zeuzem, J. Green, K. K. Patel

Journal of Viral Hepatitis. 2006;13(6):377-386

Link1 Link2

Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients

Youn Jae Lee

The Korean Journal of Hepatology. 2008;14(4):443

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.